news
FDA PMA application update
Our Premarket Approval application seeking approval for the use of Tumor Treating Fields therapy together with standard systemic therapies for the treatment of non-small cell lung cancer, following progression on or after platinum-based therapy, has been accepted for filing by the U.S. FDA.
learn morenews
TRIDENT enrollment complete
The final patient has been enrolled in the global phase 3 TRIDENT clinical trial evaluating the safety and efficacy of initiating Optune Gio® concurrent with radiation therapy and temozolomide for the treatment of adult patients with newly diagnosed glioblastoma.
learn morePatients, caregivers and their families are at the heart of our mission. That is why we are proud to support the “Empowering Caregivers” webinar from @theABTA. If you are a #caregiver or know one, learn more. http://bit.ly/MarchPFM2024 #patientforward #BTSM
A late breaking abstract with results of an exploratory subgroup analysis of the phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 clinical trial was selected as a best oral presentation and shared yesterday at the @ESGO_society 2024 Congress. #ESGO2024 https://www.novocure.com/innovate-3-late-breaking-abstract-selected-as-a-best-oral-presentation-at-esgo/
A year ago, we announced the availability and reimbursement of TTFields therapy in France. Since then, more than 350 patients there have used our therapy.
Today, we reported financial results for the quarter and full year ended December 31, 2023. Learn more: https://www.novocure.com/novocure-reports-fourth-quarter-and-full-year-2023-financial-results-and-provides-company-update/
This month, @PanCAN is sharing educational resources, research, and highlights on how the #pancreaticcancer community is addressing health inequities and improving the lives of everyone touched by this disease. Learn more at http://pancan.org/blackcommunity
We are proud to continue supporting the @HeadfortheCure Foundation in their work of raising awareness of brain cancer and inspiring hope for patients and caregivers. We are making a difference together. #braincancer #glioblastoma